GO:0061006 regulation of cell proliferation involved in kidney morphogenesis: Cellular Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0061006 describes any process that modulates the frequency, rate or extent of cell proliferation that contributes to the shaping of the kidney.
• Kidney morphogenesis depends on tightly controlled proliferation, differentiation, and extracellular matrix remodeling.
• Key signaling pathways include EGFR, Wnt, FGF, BMP, and microRNA networks that fine-tune proliferation during nephrogenesis.
• Dysregulation of these processes is linked to renal developmental defects, cystic kidney diseases, and renal cell carcinoma.
• Experimental models such as conditional knockout, knock-in reporters, and overexpression in zebrafish, mouse, and human organoids enable functional dissection.
• CRISPR-based screens and bioinformatics can identify novel regulators of kidney cell proliferation.
Description
The Gene Ontology term GO:0061006, regulation of cell proliferation involved in kidney morphogenesis, defines the biological processes that control the rate, frequency, and extent of cell division specifically during the shaping of the kidney. This term is critical for understanding how a relatively small pool of progenitor cells expands and patterns into the complex architecture of the mature kidney, including nephrons, collecting ducts, and interstitium. Disruption of these regulatory mechanisms leads to congenital anomalies of the kidney and urinary tract (CAKUT), cystic diseases, and predisposes to renal cancer. Researchers studying kidney development, regeneration, and disease rely on this ontology term to annotate gene functions and to design experiments that test how specific genes modulate proliferative behavior in renal tissues.
regulation of cell proliferation involved in kidney morphogenesis At A Glance
| GO ID | GO:0061006 |
|---|---|
| GO term | regulation of cell proliferation involved in kidney morphogenesis |
| Ontology | biological_process |
| Synonym | none |
| Major function | Modulation of cell division rate and extent during kidney development |
| Related processes | Kidney morphogenesis, cell proliferation, nephrogenesis, ureteric bud branching |
| Key signaling pathways | EGFR, Wnt, FGF, BMP, microRNAs |
| Disease relevance | CAKUT, cystic kidney disease, renal cell carcinoma |
What Is GO:0061006?
GO:0061006 encompasses any process that modulates the frequency, rate, or extent of cell proliferation that contributes to the shaping of the kidney. It includes positive and negative regulation of proliferation, such as growth factor signaling, cell cycle control, and interactions with the extracellular matrix, all within the context of kidney morphogenesis.
Why Is regulation of cell proliferation involved in kidney morphogenesis Important in Cell Biology?
Understanding GO:0061006 is essential because precise control of cell proliferation is a prerequisite for normal kidney development, and its dysregulation underlies a spectrum of renal pathologies. The term provides a framework for annotating genes that act as brakes or accelerators of proliferation during morphogenesis, thereby linking developmental biology to clinical conditions such as congenital kidney malformations and cancer.
• Defects in proliferative regulation cause renal hypoplasia or hyperplasia.
• Altered proliferation contributes to cyst formation in polycystic kidney disease.
• MicroRNAs regulate programmed cell death and proliferation in renal diseases.
• EGFR signaling is a key modulator of kidney development and repair.
• Extracellular matrix remodeling influences proliferative signaling during nephrogenesis.
• Matrix metalloproteinases affect kidney development by modulating growth factors.
• Epithelial-mesenchymal transition (EMT) is linked to morphogenetic proliferation.
• Centriole maintenance proteins like SSNA1 may influence cell division in renal progenitors.
• Dysregulated proliferation is a hallmark of Wilms tumor and renal cell carcinoma.
• Modeling GO:0061006 aids in identifying therapeutic targets for kidney regeneration.
What Happens During regulation of cell proliferation involved in kidney morphogenesis?
Initiation of nephrogenesis and progenitor expansion
In simple terms: Kidney development starts with a pool of cells that must multiply to form enough building blocks.
During early kidney morphogenesis, the ureteric bud invades the metanephric mesenchyme, triggering reciprocal signaling that induces proliferation of nephron progenitor cells. This expansion is regulated by growth factors such as FGF and BMP, and by transcription factors like SIX2 and WT1. The rate of proliferation must be tightly controlled to ensure adequate nephron endowment.
Signaling pathways controlling proliferation
In simple terms: Chemical signals tell kidney cells when to divide and when to stop.
EGFR signaling is a major driver of proliferation in developing nephrons, and its dysregulation leads to abnormal kidney architecture. Wnt9b and Wnt4 promote proliferation and differentiation of renal progenitors. MicroRNAs also modulate these pathways by targeting cell cycle regulators and apoptotic genes.
Extracellular matrix and proliferation
In simple terms: The scaffold around cells sends signals that affect their division.
The extracellular matrix (ECM) provides both structural support and biochemical cues that regulate proliferation during kidney development. Matrix metalloproteinases (MMPs) remodel the ECM, releasing growth factors that stimulate proliferation. Integrin-mediated adhesion to ECM components modulates cell cycle progression in renal epithelial cells.
Termination of proliferation and differentiation
In simple terms: Once enough cells are made, they stop dividing and become specialized.
As nephrogenesis proceeds, proliferating progenitors exit the cell cycle and undergo differentiation into specialized epithelial cells. This transition is regulated by cell cycle inhibitors such as p27 and by microRNAs that promote differentiation. EMT-like processes contribute to the morphological changes required for tubule formation.
Ciliary and centriolar regulation
In simple terms: Tiny hair-like structures on cells help sense flow and control division.
Primary cilia on renal epithelial cells sense fluid flow and transmit signals that regulate proliferation. Defects in ciliary proteins lead to cystic kidney diseases characterized by uncontrolled proliferation. Centriole maintenance proteins such as SSNA1 ensure proper centrosome function and mitotic fidelity in proliferating cells.
Key Genes Involved in GO:0061006 regulation of cell proliferation involved in kidney morphogenesis
The following genes and proteins are key players in the regulation of cell proliferation during kidney morphogenesis, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EGFR | Promotes proliferation via MAPK and PI3K pathways | Knockout models show renal hypoplasia; target for regeneration studies |
| WNT9B | Induces proliferation of nephron progenitors | Essential for ureteric bud branching; mutations linked to CAKUT |
| WNT4 | Regulates proliferation and differentiation of renal progenitors | Knockout causes renal agenesis; studied in organoids |
| FGF8 | Stimulates progenitor proliferation | Conditional knockout affects nephron number |
| BMP4 | Modulates proliferation and apoptosis | Dysregulation leads to cystic kidneys |
| SIX2 | Maintains progenitor pool | Lineage tracing and knockout models |
| WT1 | Controls proliferation and differentiation | Mutations cause Wilms tumor and nephropathy |
| MMP2 | Remodels ECM to release growth factors | Knockout affects kidney development |
| MMP9 | Degrades ECM components | Involved in nephrogenesis and repair |
| ITGB1 | Integrin subunit mediating ECM signaling | Conditional knockout impairs nephrogenesis |
| p27 (CDKN1B) | Cell cycle inhibitor | Regulates proliferation exit; knockout causes hyperplasia |
| miR-17-92 | Cluster of microRNAs promoting proliferation | Overexpression linked to Wilms tumor |
| miR-200 | Inhibits EMT and proliferation | Downregulated in renal fibrosis |
| SSNA1 | Centriole maintenance | Mutations affect mitosis; potential role in renal cysts |
| PKD1 | Ciliary signaling, inhibits proliferation | Mutations cause ADPKD with hyperproliferation |
| PKD2 | Calcium channel in cilia | Mutations cause ADPKD |
| VHL | Regulates HIF degradation | Loss leads to renal cell carcinoma with increased proliferation |
How Is regulation of cell proliferation involved in kidney morphogenesis Regulated?
The regulation of cell proliferation during kidney morphogenesis is orchestrated by a network of signaling pathways, including EGFR, Wnt, FGF, BMP, and Notch, as well as microRNAs and cell cycle regulators. Extracellular matrix composition and mechanical cues also modulate proliferative responses. Dysregulation of these pathways can lead to abnormal kidney development or disease.
regulation of cell proliferation involved in kidney morphogenesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| WT1 | Wilms tumor, nephropathy | Conditional knockout mouse, human organoids |
| PKD1 | Autosomal dominant polycystic kidney disease | Knockout mouse, zebrafish |
| VHL | Renal cell carcinoma | Knockout cell lines, xenografts |
| EGFR | Renal hypoplasia, cancer | Overexpression and knockout models |
| MMP9 | Kidney development defects | Zebrafish knockdown, mouse knockout |
Congenital anomalies of the kidney and urinary tract (CAKUT)
Mutations in genes that regulate proliferation during kidney morphogenesis, such as WNT9B, WT1, and SIX2, are associated with CAKUT, leading to renal hypoplasia or agenesis. Disrupted EGFR signaling also contributes to congenital kidney defects.
Polycystic kidney disease
Defects in ciliary proteins like PKD1 and PKD2 cause uncontrolled proliferation of renal epithelial cells, resulting in cyst formation and progressive kidney enlargement. MicroRNAs that regulate proliferation and apoptosis are also implicated in cystic diseases.
Renal cell carcinoma
Dysregulation of proliferation regulators, including VHL and microRNAs, contributes to renal cell carcinoma. Loss of VHL leads to constitutive HIF activation and increased proliferation. EGFR overexpression is also observed in some renal tumors.
Wilms tumor
Wilms tumor arises from aberrant proliferation of nephron progenitors. Mutations in WT1 and overexpression of miR-17-92 cluster are linked to tumorigenesis.
From regulation of cell proliferation involved in kidney morphogenesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate proliferation during nephrogenesis? | Conditional knockout mouse (e.g., Six2-Cre) |
| What is the effect of a point mutation in gene Y on kidney development? | Knock-in mouse with point mutation |
| Where is protein Z expressed during kidney morphogenesis? | Tagged knock-in (e.g., GFP) in mouse or zebrafish |
| Does overexpression of gene W cause hyperproliferation? | Transgenic overexpression in zebrafish or mouse |
| Can CRISPR screen identify novel regulators of kidney cell proliferation? | Pooled CRISPR knockout library in human organoids |
| How does microRNA M affect renal progenitor proliferation? | miRNA mimic/inhibitor in organoid culture |
How to Study the regulation of cell proliferation involved in kidney morphogenesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Gene expression changes | Identify proliferation-associated genes in kidney development |
| scRNA-seq | Cell-type-specific expression | Dissect progenitor heterogeneity |
| EdU/BrdU incorporation | DNA synthesis (proliferation) | Quantify proliferation in tissue sections |
| Immunofluorescence | Protein localization and expression | Visualize proliferating cells and signaling proteins |
| Western blot | Protein levels and phosphorylation | Validate signaling pathway activation |
| CRISPR screen | Gene function on proliferation | Discover novel regulators |
| Organoid culture | 3D growth and proliferation | Model kidney development and disease |
Transcriptomics and single-cell RNA sequencing
RNA-seq and scRNA-seq can identify genes and pathways differentially expressed during kidney morphogenesis, revealing regulators of proliferation.
Imaging and lineage tracing
Live imaging of fluorescent reporters in zebrafish and mouse models allows visualization of proliferating cells and their contribution to kidney structures.
Proteomics and phosphoproteomics
Mass spectrometry-based proteomics can quantify signaling changes in response to growth factors, identifying phosphorylation events that regulate proliferation.
CRISPR screens and functional genomics
Pooled CRISPR knockout screens in renal organoids or cell lines can systematically identify genes that modulate proliferation under defined conditions.
How CRISPR Can Be Used to Study GO:0061006 regulation of cell proliferation involved in kidney morphogenesis
Knockout
CRISPR knockout of candidate genes in renal cell lines or organoids can determine whether they are required for proliferation during kidney morphogenesis. For example, knocking out EGFR reduces proliferation and impairs nephron formation.
Point Mutation
Introducing precise point mutations (e.g., in PKD1 or WT1) via CRISPR can model human disease variants and assess their impact on proliferative signaling.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) or luciferase allows real-time monitoring of proliferation-related gene expression and cell tracking in developing kidneys.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression can test whether increased dosage of a gene (e.g., miR-17-92) drives hyperproliferation and tumorigenesis.
How EDITGENE Supports regulation of cell proliferation involved in kidney morphogenesis Research
Researchers studying regulation of cell proliferation involved in kidney morphogenesis-related genes often need to determine whether a candidate gene is causally involved in proliferative control, and to dissect the precise molecular mechanisms. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for regulation of cell proliferation involved in kidney morphogenesis research.
Frequently Asked Questions About regulation of cell proliferation involved in kidney morphogenesis
What is GO:0061006?
GO:0061006 is a Gene Ontology term for regulation of cell proliferation involved in kidney morphogenesis, describing processes that modulate cell division during kidney development.
What genes are involved in regulation of cell proliferation involved in kidney morphogenesis?
Key genes include EGFR, WNT9B, WNT4, FGF8, BMP4, SIX2, WT1, MMP2, MMP9, and microRNAs such as miR-17-92.
How does EGFR signaling regulate kidney cell proliferation?
EGFR activates MAPK and PI3K pathways to promote proliferation of nephron progenitors; its dysregulation leads to renal hypoplasia or cancer.
What diseases are associated with dysregulated kidney cell proliferation?
Diseases include CAKUT, polycystic kidney disease, Wilms tumor, and renal cell carcinoma.
What model systems are used to study kidney morphogenesis?
Common models include mouse, zebrafish, Xenopus, and human induced pluripotent stem cell-derived organoids.
How can CRISPR be used to study kidney cell proliferation?
CRISPR knockout, knock-in, point mutation, and overexpression can dissect gene function in renal cells and organoids.
What is the role of microRNAs in kidney cell proliferation?
MicroRNAs such as miR-17-92 promote proliferation, while miR-200 inhibits it; they regulate cell cycle and apoptosis.
How does the extracellular matrix influence kidney cell proliferation?
ECM components and MMPs modulate growth factor availability and integrin signaling, affecting proliferation during nephrogenesis.
What is the link between cilia and kidney cell proliferation?
Primary cilia sense flow and regulate proliferation; defects in ciliary proteins like PKD1 cause cystic kidney disease with hyperproliferation.
What methods are used to measure cell proliferation in kidney development?
Methods include EdU/BrdU incorporation, immunofluorescence for Ki67, flow cytometry, and live imaging of fluorescent reporters.
Conclusion
GO:0061006 provides a precise ontological framework for the regulatory processes that control cell proliferation during kidney morphogenesis. Understanding these mechanisms is crucial for deciphering congenital kidney defects, cystic diseases, and renal cancers. Leveraging CRISPR-based models and multi-omics approaches will continue to reveal novel regulators and therapeutic targets.
References
- 1. Tito C et al.. 2025. EGF receptor in organ development, tissue homeostasis and regeneration.. J Biomed Sci 32(1):24 PMID: 39966897
- 2. Nakaya Y et al.. 2013. EMT in developmental morphogenesis.. Cancer Lett 341(1):9-15 PMID: 23462225
- 3. Agostini L et al.. 2025. Structural insights into SSNA1 self-assembly and its microtubule binding for centriole maintenance.. Nat Commun 16(1):7512 PMID: 40804232
- 4. Kuure S et al.. 2000. Kidney morphogenesis: cellular and molecular regulation.. Mech Dev 92(1):31-45 PMID: 10704886
- 5. Zhang Y et al.. 2023. Role of microRNAs in programmed cell death in renal diseases: A review.. Medicine (Baltimore) 102(15):e33453 PMID: 37058073
- 6. Paces-Fessy M. 2014. [Cilia and renal cysts].. Med Sci (Paris) 30(11):1024-33 PMID: 25388585
- 7. Lelongt B et al.. 2003. Role of extracellular matrix in kidney development and repair.. Pediatr Nephrol 18(8):731-42 PMID: 12811645
- 8. Haas CS et al.. 2004. Matrix metalloproteinases in renal development.. Connect Tissue Res 45(2):73-85 PMID: 15763922
